Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, a ribosome inactivating protein from the plant Bougainvillea spectabilis.International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization. It has undergone preclinical development for the treatment of ovarian cancer and other solid tumors.
References